Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.180
-0.220 (-6.47%)
At close: Mar 6, 2026, 4:00 PM EST
3.260
+0.080 (2.52%)
After-hours: Mar 6, 2026, 5:05 PM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $26.86 million as of March 6, 2026. Its market cap has increased by 61.11% in one year.
Market Cap
26.86M
Enterprise Value
11.13M
1-Year Change
61.11%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $26.86M, a decrease of -86.01%. That is a compound annual growth rate of -32.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 26.86M | -32.49% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 28.74M |
| IGC Pharma | 28.73M |
| Kyntra Bio | 28.16M |
| Reviva Pharmaceuticals Holdings | 28.14M |
| AEON Biopharma | 27.12M |
| Passage Bio | 26.83M |
| Hyperion DeFi | 26.49M |
| FibroBiologics | 26.03M |